Novaskin Llc. cooperates with leading scientific and educational institutions of Russia – Moscow State University, Perm State Research University, Institute of Theoretical ond Experimental Biophysics of the Russian Academy of Sciences, Institute of Genetics of Industrial Microorganisms and others.
When developing new drugs, the company performs a full range of preclinical and clinical studies, including the studies of toxicity, allergenic reactions, teratogenic action, mutagenicity, oncogenic action, pharmacokinetics and others.
When developing medical cosmetics products, the company uses a specially designed cellular test system to investigate their safety and effectiveness. In addition, the ingredients included in the products undergo analytical control using advanced HPLC (high-efficiency liquid chromatography), spectroscopy, electron microscopy and other methods.